FDA Approves First Medication For Common Form Of Liver Inflammation
The medication activates a thyroid hormone receptor in the liver to help reduce fat accumulation.
The FDA has approved the first medication for a common form of liver inflammation. ‘Rezdiffra’ would be used to treat nonalcoholic steatohepatitis, also known as ‘NASH,’ which happens when the liver becomes inflamed due to excess fat cells. The medication activates a thyroid hormone receptor in the liver to help reduce fat accumulation. It would be taken daily by mouth…